Valuation Ipsen London S.E.

Stocks

Market Closed - London S.E. Other stock markets 16:30:00 16/07/2026 BST			5-day change	1st Jan Change
157.30 ^EUR	-1.41%		-5.18%	+32.52%

07-14	Where would AI lead Pharma in the long run?
07-13	Positive news for Ipsen's Iqirvo

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,964	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	32.69%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,538	10,538	9,709
Change	-	16.81%	12.22%	1.81%	2.28%	25.06%	-8.66%	-7.87%
P/E	10.4x	12.9x	14x	26.7x	22.4x	14.5x	14x	14x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.62x	2.22x	1.92x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	3.62x	40.94x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	3.02x	2.88x	2.76x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.69x	2.34x	2.07x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.87x	6.21x	5.8x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.92x	7.11x	6.59x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	10.5x	9.19x	8.29x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	9.54%	10.9%	12.1%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.518	1.502	1.611
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.95%	0.94%	1%
EPS ²	7.76	7.81	7.73	4.15	5.32	11.04	11.47	11.51
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	13.7%	13.1%	14%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,287	4,501	4,690
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,678	1,696	1,674
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,457	1,483	1,474
Net income ¹	646.6	647.5	647.2	347.3	444.5	945.1	974.9	973.7
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,426	-2,426	-3,255
Reference price ²	80.50	100.50	107.90	110.70	119.00	160.60	160.60	160.60
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	82,100	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.38x	12.29x	25.6x	0.58%	1,031B
JOHNSON & JOHNSON	26.33x	6.06x	16.38x	2.17%	595B
ABBVIE INC.	30.03x	7.25x	14.87x	2.81%	431B
ROCHE HOLDING AG	17.64x	4.37x	10.78x	3.03%	326B
NOVARTIS AG	21.13x	5.43x	13.15x	2.91%	277B
ASTRAZENECA PLC	21.17x	4.46x	12.34x	1.97%	263B
NOVO NORDISK A/S	14.47x	5.42x	11.17x	3.43%	224B
AMGEN INC.	23.5x	6.23x	11.02x	2.81%	193B
GILEAD SCIENCES, INC.	-47.44x	5.68x	31.37x	2.46%	164B
Average	15.69x	6.36x	16.30x	2.47%	389.37B
Weighted average by Cap.	23.19x	7.66x	17.90x	2.04%